Fine, Richard E.
Gilmore, Richard C.
Tomkovich, Kenneth R.
Dietz, Jill R.
Berry, Michael P.
Hernandez, Lydia E.
Columbus, Karen S.
Seedman, Susan A.
Fisher, Carla S.
Han, Linda K.
Manahan, Eric R.
Hicks, Randy D.
Vaidya, Rashmi P.
Curcio, Lisa D.
Sevrukov, Alexander B.
Kenler, Andrew S.
Taback, Bret
Chen, Margaret
Miller, Megan E.
Gold, Linsey
Anglin, Beth V.
Aoun, Hussein D.
Simmons, Rache M.
Feldman, Sheldon M.
Boolbol, Susan K.
Article History
Received: 22 May 2024
Accepted: 29 August 2024
First Online: 16 September 2024
Disclosures
: Andrew Kenler was the Medical Director of IceCure for approximately 5 years and during the time period of this study, and was paid for his time as Medical Director. That relationship ended approximately 1 year ago. Kenneth Tomkovich: Stipend received for data entry for patients enrolled in the trial to CentraState Medical Center by IceCure Medical. The probes and cryoablation unit were provided by IceCure Medical to conduct the trial. I received no personal funds for conducting the trial or for the preparation of this manuscript. Neither I nor my medical institution have any relevant conflicts of interest in conducting this research. Richard Fine: West Cancer Center and Research Institute (author’s institution) received financial support for conducting the clinical trial. Served on the original scientific advisory board that participated in the Ice3 trial protocol design. Expenses were reimbursed for travel to Chicago, IL, in 2014. Susan Seedman profited $280 from the prior purchase and sale of publicly traded stock. Richard C. Gilmore, Jill R. Dietz, Michael P. Berry, Lydia E. Hernandez, Karen S. Columbus, Carla S. Fisher, Linda K. Han, Eric R. Manahan, Randy D. Hicks, Rashmi P. Vaidya, Lisa D. Curcio, Alexander B. Sevrukov, Bret Taback, Margaret Chen, Megan E. Miller, Linsey Gold, Beth V. Anglin, Hussein D. Aoun, Rache M. Simmons, Sheldon M. Feldman, and Susan K. Boolbol have no conflict of interest to declare that may be relevant to the contents of this study.